Drawing for NUBIOME

USPTO serial 86047111

NUBIOME

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YOUNG, CARRIE SKYE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUBIOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Enzymes for use in the dairy industry; Enzymes for use in the food industry; Enzymes for use in the manufacture of nutraceuticals; Enzymes for use in the manufacture of pet food; Enzymes to assist in digestion for use in the manufacture of animal feeds; Probiotic compositions for use as ingredients for food and beverages, namely, probiotic bacteria and probiotic bacterial culturesACTIVE—
005Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed additives, namely, enzymes for use in animal feeds to assist in digestion; Animal feed supplements; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for autoimmune and digestive conditions; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for autoimmune and digestive conditions; Enzyme dietary supplements; Enzyme food supplements; Enzymes for medical purposes; Enzymes for veterinary purposes; Food supplements; Food supplements for autoimmune and digestive conditions; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for autoimmune and digestive conditions; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplements for autoimmune and digestive conditions; Nutritional supplements in the form of capsules, pills, powders, gels, liquids; Nutritional supplements, namely, probiotic compositions; Powdered nutritional supplement drink mix; Probiotic animal feedACTIVE—
020Plastic bottle caps for storing powdered nutritional supplements and for dispensing those supplements into the bottleACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 5, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 5, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 8, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 8, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 19, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 28, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 28, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 5, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2014ALIEASSIGNED TO LIE—
Jan 24, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2013DOCKASSIGNED TO EXAMINER—
Sep 4, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance